Cargando…
Economic Evaluation of Letrozole for Early Breast Cancer in a Health Resource-Limited Setting
OBJECTIVE: Long-term aromatase inhibitor (AI) therapy is expected to improve the health outcomes with high health resource consumption in early breast cancer. The aim of the study was to assess the cost-effectiveness of letrozole for postmenopausal women with estrogen receptor positive early breast...
Autores principales: | Ye, Ming, Lu, Jingsong, Yang, Fan, Wu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098874/ https://www.ncbi.nlm.nih.gov/pubmed/30155484 http://dx.doi.org/10.1155/2018/9282646 |
Ejemplares similares
-
Subgroup Economic Analysis for Glioblastoma in a Health Resource-Limited Setting
por: Wu, Bin, et al.
Publicado: (2012) -
The early days of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2007) -
The early days of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2008) -
Economic Evaluation of First-Line Treatments for Metastatic Renal Cell Carcinoma: A Cost-Effectiveness Analysis in A Health Resource–Limited Setting
por: Wu, Bin, et al.
Publicado: (2012) -
A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
por: Aphinives, Potchavit, et al.
Publicado: (2015)